![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 14, 2021 8:47:42 AM
'Pisd', for contracts/revenues; so "manufacture"? or trial?, Labs losing my confidence atm... gl
I expect to leave my Medi shares to ride throughout the new management's international expansion and MediPharm Branded Product expansion which may take years.
It's a crap shoot to see if they can execute on the turn-around plan, or end up "a failed also ran" trading near $0, with a diluted O/S between 500,000,000 to 1,000,000,000?
The last MediPharm ER was a huge downer. I was hoping for $10M. Instead they posted $5.5M, a decline from $6.1.
I have no idea if MediPharm can successfully implement the new business plan. This morning's news is a step in the right direction. Let's see how they leverage it.
MediPharm is hoping for EU and South American cannabis growth. They need a lot of new medical customers ready to place orders and feed the supply chain to end users.
Therefore, MediPharm's focus is on the future. We need results now.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM